Dr Lalchandani Labs Ltd. Stock Analysis 541299.BO

Dr. Lalchandani Labs Ltd. engages in the provision of diagnostic and related healthcare services. The company is headquartered in New Delhi, Delhi. The company went IPO on 2018-05-09. The firm is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, virology, cytology, other pathological investigations and immunoassay, immuno-histochemistry, molecular pathology, DNA and genetic testing. Through its integrated network, it offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The firm has its own blood banking services through its sister concern CPC blood bank. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.